Xenon Pharmaceuticals
XENE
XENE
32 hedge funds and large institutions have $25.9M invested in Xenon Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $27.5M → $25.9M (-$1.63M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$311K | |
| 2 | +$261K | |
| 3 | +$214K | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$155K |
| 5 |
DMK
David M. Knott
|
+$139K |
Top Sellers
| 1 | -$673K | |
| 2 | -$565K | |
| 3 | -$278K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$214K |
| 5 |
IPC
Invesco Private Capital
New York
|
-$96K |